Kirkland & Ellis advised Levine Leichtman Capital Partners (LLCP), a Los Angeles-based private equity firm, and its portfolio company, Therapeutic Research Center (TRC), on the sale of TRC to Colibri Group, a portfolio company of Gridiron Capital. Financial terms of the transaction were not disclosed.
TRC is a provider of independent, evidence-based continuing education and training for healthcare professionals and institutions with a particular content focus on drug therapy recommendations and medication management. The sale of TRC will be LLCP’s 18th successful exit since December 2020.
The Kirkland team was led by corporate partners Kevin Mausert, John Wilkes and Andrew Struckmeyer and associate Josh Cowin.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
